The Critical Role of Training in The Use Of Nasal Rescue Therapies
Startling statistics have revealed the magnitude of the global opioid epidemic. According to the World Health Organization (WHO), in 2018 about 58 million people worldwide used opioids, and another 35.6… Read More »
Human Factors + Webinar: Regulatory Overview
Part 1 of Noble’s Human Factors + Webinar Series: Regulatory Overview Join Noble’s Joe Reynolds and Joe Masci, along with Human Factors expert Kevin Cluff, in the first of our… Read More »
Noble Further Expands Its Human Factors Expertise with Two New Hires for Newly Created HF-Focused Positions
According to the US FDA, human factors engineering is an essential component of product development for drug delivery and medical devices. The US FDA recommends making it a robust part… Read More »
Noble Launches Human Factors Engineering Services to Support Product Development and US FDA Approval of Medical Devices and Combination Products
“Human Factors Plus” (HF+) is a natural extension of Noble’s deep understanding of the patient experience when it comes to self-administering drug therapies ORLANDO, Fla. (February 2, 2021) – Noble,… Read More »
Training Devices & Patient Education Play A Crucial Role in The Self-Injection Drug Delivery Market
The biopharmaceutical industry has experienced incredible exponential growth in recent decades. Annual revenues have increased from US$4.4 billion (£3.4 billion) in 1990 to $275 billion (£213 billion) in 2018 (a… Read More »
Noble and Aptar Pharma Launch AdhereIT®, a Connected Medical Device Solution for Disease Management, Adherence and Onboarding Patients
Crystal Lake, Illinois and Orlando, Florida (October 5, 2020) — Noble and Aptar Pharma are pleased to announce the launch of AdhereIT® — a connected, intuitive and user-friendly onboarding solution… Read More »